ALLMedicine™ Toe Amputation Center

May 10th, 2022 - Background Toe amputation is a common procedure performed by a wide variety of healthcare providers. The vast majority of toe amputations are performed on patients with a diabetic foot. [1] Although regional variation is noted, most of these proce...

Apr 21st, 2022 - Different procedures have been reported for severe and recurrent lesser toes deformity. These included DuVries metatarsophalangeal joint arthroplasty, resection arthroplasty, partial proximal phalangectomy, syndactylization, or lesser toe amputati...

Mar 14th, 2022 - It's Just a Toe Amputation.|2022|Malay DS,|

Nov 13th, 2021 - Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that affects multiple organs and is caused by inactive mutations in the TSC1 or TSC2 genes. The main symptoms of TSC are neurocutaneous syndrome and benign hamartoma formation. Not...

Aug 20th, 2021 - To compare the number of reoperations, reamputations, and new ulcers following toe amputation in diabetic and non-diabetic patients with sub-group analysis on index amputation level. One-hundred sixteen patients with a complete (CTA) or partial (P...

Nov 29th, 2018 - Amputation: Often the best option For many years there has been debate about the best management strategy for diabetic foot infection including osteomyelitis. The principles of appropriate antibiotics, surgical debridement, good wound care, and pr.

Dec 21st, 2017 - The US Food and Drug Administration (FDA) has approved the sodium/glucose cotransporter 2 (SGLT2) inhibitor ertugliflozin (codeveloped by Merck and Pfizer) for glycemic control in adults with type 2 diabetes. Ertugliflozin is approved as monothera...

Jun 11th, 2017 - SAN DIEGO – As quality measures in health care continue to grow in importance, it behooves endocrinologists to pay more attention to the mental as well as physical well-being of patients with diabetic foot conditions before and after treatment. “W.

Apr 15th, 2016 - The European Medicines Agency (EMA) has begun a review of the sodium glucose cotransporter 2 (SGLT2) inhibitor canagliflozin (Invokana, Janssen), used to treat type 2 diabetes, after an increase in amputations, mostly of the toe, was observed in a...

Aug 10th, 2015 - To the Editor: A 38-year-old black man presented with a slowly enlarging growth on the left thigh of 7 years’ duration. The lesion would occasionally scrape off but always recurred.